Cite

    Shilkrut, M. et al. (2013). The addition of low‐dose‐rate brachytherapy and androgen‐deprivation therapy decreases biochemical failure and prostate cancer death compared with dose‐escalated external‐beam radiation therapy for high‐risk prostate cancer1. Cancer. 119 (3), pp. 681-690. [Online].